文献速递腹部CT

主胰管截断伴扩张但MDCT上未见胰腺局灶性病变时对恶性狭窄的评估:一种基于CT列线图的新诊断方法

Assessment of main pancreatic duct cutoff with dilatation, but without visible pancreatic focal lesion on MDCT: a novel diagnostic approach for malignant stricture using a CT-based nomogram.
PubMed 文献 · Eur Radiol · 2022-06-21

回顾性纳入92例增强CT见主胰管截断伴扩张但无可见胰腺局灶性病变的患者,恶性组38例(41.3%)、良性组54例(58.7%)。多因素分析显示CA19-9升高、截断位于胰头/颈、截断处实质轮廓异常及伴急性胰腺炎为独立预测因素,基于此构建的CT列线图AUC为0.84(95%CI 0.77-0.90)。

要点

  • 主胰管截断伴扩张而CT未见局灶病变时,约41.3%最终为恶性,需结合CA19-9与CT征象综合判断。
  • 截断位于胰头/颈、截断处实质轮廓异常、伴急性胰腺炎及CA19-9升高提示恶性可能更高。
  • 基于上述特征的CT列线图AUC为0.84(95%CI 0.77-0.90),可辅助判断是否需进一步检查。

核心结论

  • CA19-9升高联合三项CT影像特征构建的列线图可较可靠地估计主胰管截断且无可见局灶病变患者的隐匿性胰腺恶性肿瘤风险,可能有助于决定是否进一步行诊断性检查。

研究设计与样本

  • 回顾性研究,纳入2009年至2021年间92例(平均年龄63.4±10.6岁,男63例、女29例)增强CT显示主胰管截断伴扩张但无可见胰腺局灶性病变的患者,由两名放射科医师独立评估CT影像特征,采用多因素logistic回归分析并构建列线图评估其性能。

关键影像表现/征象

  • 恶性组38例(41.3%)、良性组54例(58.7%)。
  • 多因素分析中CA19-9升高(OR 7.5,p=0.003)、截断位于胰头/颈(OR 7.6,p=0.006)、截断处实质轮廓异常(OR 13.7,p<0.001)及伴急性胰腺炎(OR 11.5,p=0.005)为胰腺恶性肿瘤的独立预测因素。

诊断标准与关键数值

  • 任意两项显著特征组合的准确率为77.2%。
  • 任意三项特征组合的特异度为100%。
  • 基于CT的列线图AUC为0.84(95%CI 0.77-0.90)。

临床应用与阅片要点

  • 对主胰管截断伴扩张而CT未见局灶病变者,阅片时应关注截断部位是否位于胰头/颈、截断处实质轮廓是否异常及是否伴急性胰腺炎。
  • 结合血清CA19-9升高情况,可使用该CT列线图估计隐匿性胰腺恶性肿瘤的可能性,以辅助决定是否进一步行诊断性检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To identify useful features to predict hidden pancreatic malignancies in patients with main pancreatic duct (MPD) abrupt cutoff and dilatation, but without visible focal pancreatic lesions on CT.

METHODS: This retrospective study included 92 patients (mean age, 63.4 ± 10.6 years, 63 men and 29 women) with MPD abrupt cutoff and dilatation, but without visible focal pancreatic lesion on contrast-enhanced CT between 2009 and 2021. Two radiologists independently evaluated the CT imaging features. Multivariable logistic regression analysis was performed to identify clinical and CT imaging features for hidden pancreatic malignancies. A nomogram was developed based on these results and assessed its performance.

RESULTS: Thirty-eight (41.3%) and 54 (58.7%) were classified into the malignant and benign groups, respectively. In the multivariable analysis, CA19-9 elevation (odds ratio [OR] 7.5, p = 0.003), duct cutoff site at the head/neck (OR 7.6, p = 0.006), parenchymal contour abnormality at the duct cutoff site (OR 13.7, p < 0.001), and presence of acute pancreatitis (OR 11.5, p = 0.005) were independent predictors of pancreatic malignancy. A combination of any two significant features showed an accuracy of 77.2%, and a combination of any three features exhibited a specificity of 100%. The CT-based nomogram showed an area under the curve (AUC) of 0.84 (95% confidence interval, 0.77-0.90).

CONCLUSIONS: The three CT imaging features and CA19-9 elevation translated into a nomogram permit a reliable estimation of hidden pancreatic malignancies in patients with MPD abrupt cutoff without visible focal pancreatic lesion. It may facilitate determining whether to proceed to further diagnostic tests.

KEY POINTS: • Isoattenuating pancreatic ductal adenocarcinoma can manifest only as an isolated main pancreatic duct (MPD) dilatation with abrupt cutoff, making it difficult to distinguish from benign strictures. • Along with the serum CA 19-9 elevation, MPD cutoff site at the pancreas head or neck, parenchymal contour abnormality at the duct cutoff site, and associated acute pancreatitis indicated a higher probability of the malignant MPD strictures. • The CT-based nomogram provided excellent diagnostic performance (AUC of 0.84) for hidden pancreatic malignancies in patients with MPD abrupt cutoff and dilatation.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lim CY, Min JH, Hwang JA, et al. Assessment of main pancreatic duct cutoff with dilatation, but without visible pancreatic focal lesion on MDCT: a novel diagnostic approach for malignant stricture using a CT-based nomogram. Eur Radiol. 2022. PMID: 35726102. doi:10.1007/s00330-022-08928-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。